abstract |
The present application discloses compounds having the following formula (I): wherein R1, R2 and R3 are as defined herein, and methods of making and using it, including as inhibitors and treatments of BMP1, TLL1 and/or TLL2 in combination with BMP1, TLL1 and/or TLL2 Use in diseases associated with TLL1 and/or TLL2 activity. |